Research and Development

Showing 15 posts of 9594 posts found.

shutterstock_360472550

Harnessing the power of the immune system

October 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, immunotherapy, pharma, pharmaceuticals

Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …
800px-flag_of_the_peoples_republic_of_china

China to accelerate drug approvals with overseas trial data

October 9, 2017 Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals

In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …

Sanofi promotes global head of diabetes to expand role

October 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical

Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The week has flown by and was packed with a number of shocking stories. With the ongoing uncertainty regarding Brexit, …
bayer_cross_2

Bayer forced to halt huge study into key drug

October 6, 2017 Medical Communications, Research and Development Bayer, Janssen, Xarelto, biotech, drugs, pharma, pharmaceutical

Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …

Merck KGaA promotes from within new MEA head

October 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, …
culture

Gonorrhoea is just the tip of the antimicrobial resistance iceberg

October 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NovaBiotics, biotech, drugs, gonorrhoea, pharma, pharmaceutical

Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …
abbvie_0

AbbVie adds biologic production capability to Singapore facility

October 4, 2017 Manufacturing and Production, Research and Development AbbVie, Singapore, biologics, pharma, pharmaceuticals

AbbVie has expanded the operational capability of its facility located at the Tuas Biomedical Park in Singapore with the addition …
amgen_hq

CytomX scores deal with Amgen worth potential $1.5bn

October 4, 2017 Research and Development, Sales and Marketing Amgen, biotech, cytomx, drugs, pharma, pharmaceutical

CytomX Therapeutics and Amgen have signed a deal that could be worth a potential $1.5 billion. The agreement will see …

Police raid French HQ of Merck KGaA over thyroid drug scandal

October 4, 2017 Manufacturing and Production, Research and Development, Sales and Marketing Levothyrox, Merck KGaA, hyperthyroidism, pharma, pharmaceuticals

Police have raided the French headquarters of German drug manufacturer Merck KGaA over a scandal concerning its thyroid treatment Levothyrox, …
cholera_infection_map

Global campaign to reduce cholera deaths by 90%

October 4, 2017 Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical

A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …
shire_image

Shire takes fight to Allergan over dry-eye drug

October 4, 2017 Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical

It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …
nih_logo

NIH funds research into infant opioid withdrawal syndrome treatment

October 3, 2017 Manufacturing and Production, Research and Development NIH, National Institutes of Health, opioid crisis, opioids, pharma, pharmaceuticals

As the US continues to be plagued by its opioid crisis, which is claiming the lives of more than 100 …

Overcoming real-world challenges to maximise the benefit of treatment for patients with multiple myeloma

October 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Takeda, multiple myeloma

Dr Antonio Palumbo, Distinguished Research Fellow Oncology, Takeda Pharmaceuticals addresses hwo far we’ve come in treating multiple myeloma, and how …
The Gateway to Local Adoption Series

Latest content